SCHEMBL5659627

SCHEMBL5659627

Cc1cc(C2(c3cc(C)c(O)c(C)c3)C(=O)N(Cc3ccccc3Cl)c3cccc(Cl)c32)cc(C)c1O

nearest known ligand 0.45

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TP53 P04637 5/20 0.45
MAPT P10636 5/20 0.45
ALDH1A1 P00352 4/20 0.42
TSHR P16473 4/20 0.42
HTT P42858 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
LMNA P02545 2/20 0.42
HSD17B10 Q99714 2/20 0.42
ALOX15 P16050 1/20 0.42
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
P2RX7 Q99572 3/20 0.40
POLB P06746 3/20 0.39
NPSR1 Q6W5P4 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5659726 0.89 TP53 (0.52) TP53MAPTALDH1A1TSHRHTT
SCHEMBL5660174 0.84 CNR1 (0.57) TP53MAPTALDH1A1TSHRHTT
SCHEMBL5658580 0.84 TP53 (0.48) TP53MAPTALDH1A1TSHRHTT
SCHEMBL5661002 0.84 TP53 (0.45) TP53MAPTALDH1A1TSHRHTT
SCHEMBL5658562 0.82 CNR1 (0.47) TP53MAPTALDH1A1TSHRHTT
SCHEMBL5660889 0.82 TP53 (0.42) TP53MAPTALDH1A1TSHRHTT
SCHEMBL5661435 0.82 TP53 (0.43) TP53MAPTALDH1A1TSHRHTT
SCHEMBL5660120 0.81 TP53 (0.41) TP53MAPTALDH1A1TSHRHTT
SCHEMBL5661178 0.81 TP53 (0.49) TP53MAPTALDH1A1TSHRHTT
SCHEMBL14457608 0.81 TP53 (0.59) TP53MAPTALDH1A1TSHRHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7250442-B2 Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators ELI LILLY AND COMPANY (US) 2007-07-31 US disclosed
US-7250442-B2 Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators ELI LILLY AND COMPANY (US) 2007-07-31 US disclosed
US-7250442-B2 Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators ELI LILLY AND COMPANY (US) 2007-07-31 US disclosed
US-20050054712-A1 Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators ELI LILLY AND COMPANY 2005-03-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050054712-A1 Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators NR3C2, NR5A1, NR5A2 TP53 3370/4885MAPT 3588/4885ALDH1A1 723/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.